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Summary 
Lymphotoxin ot (LT-cx) may form secreted homotrimers binding to p55 and p75 tumor necro- 
sis factor (TNF) receptors or cell surface-bound heterotrimers with LT-[3 that interact with the 
LT-[3 receptor. Genetic ablation of LT-ot revealed that mutant mice have no detectable lymph 
nodes or Peyer's patches and that the organization of  the splenic white pulp in T and B cell areas 
is disturbed. In this report we describe a novel function for the p55 TNF receptor during on- 
togeny and demonstrate that mice deficient for p55 completely lack organized Peyer's patches. 
In contrast, lymph nodes and spleen are present in p55-deficient mice and lymphocytes segre- 
gate normally into B and T  cell areas in these organs. Lamina propria and intraepithelial lym- 
phocytes of the small intestine were detected in normal number and distribution in p55 mutant 
mice. Lymphocytes and endothelial cells from p55-deficient mice express normal levels of ad- 
hesion molecules considered important for lymphocyte migration to mucosal organs; this indi- 
cates that the lack of Peyer's patches does not result from a defect in lymphocyte homing. In 
summary,  the  p55  receptor for TNF  selectively mediates  organogenesis  of Peyer's patches 
throughout ontogeny, suggesting that the effects of LT-0~ on the development of  lymphoid or- 
gans may be mediated by distinct receptors, each functioning in an organ-specific context. 
T 
NF-ot  and  lymphotoxin  et  (LT-c~,  also  designated 
TNF-[3)  affect the growth, differentiation, and func- 
tion  of multiple  cell types.  Both cytokines are  important 
mediators of inflammation and cellular immune responses 
(1-4). The multiple biological activities of  TNF-c~ and LT-et 
homotrimers are mediated by two distinct cell surface re- 
ceptors of 55  (TNFRp55) and 75 kD  (TNFRp75). LT-ot 
can also  associate  with LT-[3 to form a type II cell mem- 
brane-bound heterotrimer that may engage the LT-[3 re- 
ceptor, originally described as a TNF receptor-related pro- 
tein (5). 
Via gene-targeted mice, a crucial role of LT-ot for the 
development of peripheral lymphoid organs has been dem- 
onstrated. LT-ot  -/- mice have no detectable lymph nodes 
or Peyer's patches and the organization of the splenic white 
pulp in T and B cell areas is disturbed (6, 7). Elevated num- 
bers of IgM + B cells were seen in the spleen and periphery 
of these  mice.  In  some  of these  mutant  mice,  abnormal 
lymph node-like structures were observed, the majority of 
which  were  located in  the  mesenteric  fat  (7).  Although 
these studies demonstrated a fundamental role of LT-et for 
the development of lymphoid organs, the cellular receptors 
mediating these effects were not identified. For TNF-ot, a 
putative  role  in  lymphatic  tissue  development  has  been 
suggested by observations demonstrating TNF-a  mRNA 
expression in mouse  embryos as well as fetal thymus and 
spleen (8, 9). However, the fact that LT-oL  -/- mice exhibit 
defective  lymphoid  organ  development  despite  normal 
TNF-et expression suggests  that  the  function of LT-ot in 
development cannot be compensated for by TNF-ot. 
Targeted disruption of the gene for TNFRp55 revealed 
a critical function of this receptor for generating a protec- 
tive  immune  response  against  the  facultative intracellular 
bacterium Listeria monocytogenes (10,  11). In addition, loss of 
TNFRp55 renders mice resistant to the toxic effects of LPS 
(10,  11)  or  Staphylococcus aureus enterotoxin B  (10)  after 
sensitization  with  D-galactosamine.  Thymocyte develop- 
ment  and  absolute  lymphocyte  numbers  in  spleen  and 
lymph nodes are normal in TNFRp55 -/- mice, and clonal 
deletion of potentially self-reactive T  cells is not impaired 
(10). Mice deficient for TNFRp75 show normal T  cell de- 
velopment and  activity and  a  normal phenotype of lym- 
phoid  organs  (12).  Challenge  with  sublethal  doses  of L. 
monocytogenes revealed increased mortality of TNFRp75 -/- 
mice, although sensitivity to infection appeared less severe 
than  in  TNFRp55-deficient  mice  (12).  In  contrast  to 
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not result in resistance to LPS-induced toxicity, but suscep- 
tibility to TNF-induced death is reduced (12). 
In this report we describe a novel function of TNFRp55 
in  lymphoid  organogenesis  and  show  that  TNFRp55 -/- 
mice  exhibit  a  selective  defect  in  the  development  of 
Peyer's patches.  In contrast, other secondary lymphatic or- 
gans, including peripheral  lymph nodes,  mesenteric lymph 
nodes, and spleen, were present in TNFRp55 -/- mice and 
appeared  morphologically normal.  Expression  of lympho- 
cyte and endothelial adhesion molecules considered to reg- 
ulate  lymphocyte traffic  to mucosal lymphoid organs  was 
not altered in TNFRp55 -/-  mice.  These findings indicate 
that TNFRp55 selectively mediates organogenesis of Peyer's 
patches throughout ontogeny. 
Materials and Methods 
Antibodies.  mAbs used included rat anti-murine integrin c~4, 
PS/2  (American Type Culture  Collection,  [ATCC], Rockville, 
MD),  rat  anti-routine  LFA-1 ct subunit,  FD441.8  (ATCC), rat 
anti-mufine integrin [37, Fib30 (13), rat anti-murine mucosal ad- 
dressin cellular adhesion molecule 1 (MAdCAM-1), R3-3 c12C7 
(14),  and rat anti-murine  L-selectin,  MEL-14  (ATCC).  Rat  or 
hamster  mAbs  against  CD45R/B220  (RA3-6B2),  CD3  (145- 
2Cll),  CD4  (RM4-5),  CD8a (53-6.7),  or IgA (R5-140)  were 
purchased from PharMingen (San Diego, CA). 
Immunohistochemistry.  The tissue samples were snap-frozen in 
2-methylbutane  prechilled by liquid nitrogen. Cryostat sections were 
prepared at 8 ~m, fixed in cold acetone for 10 rain,  dried,  and 
stored at -80~  Endogenous peroxidase  activity was blocked by 
preincubation of the sections with methanol and H202. The sec- 
tions were incubated for 30 rain with 100 ~1 of the mAbs. After 
three washes in PBS,  100 I.L1 of secondary mouse anti-rat IgG or 
mouse anti-hamster IgG antibody labeled  with peroxidase  (Dia- 
nova, Hamburg, Germany) was added for 30 rain. ALl incubations 
were  carried  out in  a  moist,  light-protected  chamber at  room 
temperature.  Nonspecific background staining  was  reduced  by 
preincubation of the peroxiclase-conjugated  antiserum with nor- 
mal mouse serum. The sections  were rinsed  again  in PBS, fixed 
in 0.1% glutardialdehyde for 5 min,  and stained for 10 rain in 
50  mM  acetate  buffer  containing  0.01%  H20  2 and  5  mg/ml 
3-amino-9-ethylcarbazole (Sigma Chemical Co., St. Louis, MO), 
which was dissolved in N,N'-dimethylformamide. After extensive 
washing in PBS, the slides were counterstained with Mayer's he- 
matoxylin for 10 rain and mounted with glycerol-gelatin. 
Flow CytometryAnalysis.  Indirect  immunofluorescence  flow 
cytometric assays for c~4, [37, LFA-1, and L-selectin  surface  ex- 
pression on popliteal  lymph node cells of TNFRp55 -/- and syn- 
genic C57B1/6 mice were performed. Lymphocytes were incu- 
bated with  saturating  amounts of rat  mAbs for 30 rain at  4~ 
washed two times with PBS containing 1% BSA, and then stained 
with FITC-conjugated mouse anti-rat  IgG F(ab')2 fragments (Dia- 
nova) for 30 n'fin at 4~  After washing with PBS, cells were fixed 
in  1%  paraformaldehyde,  and  fluorescence  was  analyzed  on  an 
EPICS XL cytometer (Coulter Corp., Hialeah,  FL). 
Results and Discussion 
Development  of lymphoid  organs  was  investigated  in 
mice rendered  deficient  for TNFRp55  by gene  targeting 
(10).  Gross inspection  as well  as histologic examination  of 
animals  at  8-12  wk  of age  revealed  that  TNFRp55-defi- 
cient  mice  completely  lacked  organized  Peyer's  patches 
(Table  1). In wild-type C57B1/6 mice, the total number of 
Peyer's patches  varied from 5  to  8 with a mean  of 6.5  -+ 
0.6. Interestingly, in 6 out of 18 TNFRp55 -/- mice exam- 
ined,  a single, small lymphoid aggregate located in the ter- 
minal  ileum  was  detected  histologically  (Fig.  1,  b  and  c). 
Morphologically,  these  aggregates  were  clearly  distinct 
from Peyer's patches, as they were not organized into folli- 
cular structures, did not contain germinal centers, and were 
devoid of a dome area  (Fig.  1, a-c). Immunohistochemical 
analysis  demonstrated  that  these  unusual  lymphoid  struc- 
tures consisted primarily of B  cells  (Fig.  1 e), but also con- 
tained  some  CD4  T  lymphocytes  (Fig.  1 JJ  and  only few 
CD8 T  cells  (not shown). 
Intraepithelial lymphocytes were present in the small in- 
testine of mutant mice with apparently normal distribution 
and  frequency  as  demonstrated  by  immunohistochemical 
staining using mAbs directed against CD8 (Fig.  1 g) or CD3 
and integrin odELI37 (not shown).  In the lamina propria of 
TNFRp55 -/-  mice,  IgA immunoblasts were detected at a 
normal frequency (Fig. 1 h). Consistent with these observa- 
tions,  IgA  + B  cells were also shown to be present  in me- 
senteric  lymph  nodes  of mutant  mice  (data  not  shown). 
Despite profound defects in the development of lymphoid 
organs,  gut intraepithelial  lymphocytes were also observed 
in LT-oc  -/- mice (6). 
In contrast to Peyer's patches, other secondary lymphatic 
organs,  including  peripheral  lymph  nodes  (axillary,  bra- 
chial,  popliteal,  inguinal,  and  cervical  nodes),  mesenteric 
Table 1.  TNFRp55 Deficiency Results in a Selective Defect in 
Lymphoid Organogenesis 
Organs  C57B 1/6  TNFRp55 -/- 
Peyer's patches  6.5 (4)*  0 (18)* 
Peripheral  lymph nodes  4/4~  18/18 
Mesenteric lymph nodes  4/4  18/18 
Spleen  4/4  18/18 
Development  of secondary lymphatic organs was investigated in  18 
TNFRp55 -/- mice (10) and 4 wild-type C57B1/6 controls at 8-12 wk 
of  age. Presence of  lymphatic organs was monitored by gross inspection 
and confirmed by histopathological analysis. Peripheral lymph nodes 
consisted of inguinal, popliteal brachial, axillary, and cervical nodes. 
Immunohistochemistry of lymph nodes and spleen of TNFRp55 -/- 
mice revealed a normal segregation into T and B cell areas (see Fig. 2). 
*Average number  of organized Peyer's patches detected (number of 
animals examined). 
~:In 6 out of 18 TNFRp55 -/- mice examined, a single, small lymphoid 
aggregate located in  the  terminal ileum  was  detected  histologically. 
However, these aggregates were clearly distinct from Peyer's patches, as 
they were not organized into follicular structures, did not contain ger- 
minal centers, and were devoid of  a dome area. 
~Number of animals with lymphoid organs present/number  of mice 
examined. 
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munohistochemical analysis of the 
gut-associated immune  system in 
TNFRp55-deficient  mice.  For 
histopathological examination, tis- 
sues were  fixed in  10%  buffered 
formalin,  embedded  in  paraffin, 
and  tissue sections were  stained 
with hematoxylin and eosin. Rep- 
resentative  sections  of  Peyer's 
patches  derived from  wild-type 
mice (a)  or  lymphoid aggregates 
present in  the  small intestine of 
TNFRp55 -/-  mice (b and c) are 
shown.  For  immunoperoxidase 
staining,  sections  of  snap-frozen 
tissue  samples  derived  from 
TNFRp55 -/-  mice were  incu- 
bated with anti-MAdCAM-1 (d), 
anti-CD45R/B220  (e), anti-CD4 
~,  anti-CD8  (g), or anti-IgA (h) 
mAbs.  Original  magnifications 
were at 2.5 (a and b), 20 (c and d), 
10 (e and  f), and 40 (g and h). 
lymph  nodes,  and  spleen  were  present  in  TNFRp55 -/- 
mice and appeared morphologically normal. Histologic and 
immunohistochemical examination revealed that the spleen 
of mutant  mice  exhibited  a  normal  organization  of the 
white  pulp  with  T  cells  clustered  in  the  periarteriolar  re- 
gion and B  cells peripheral to the T  cell zone (Fig. 2). Me- 
senteric  and peripheral  lymph nodes also  displayed  a  nor- 
real segregation of B  and T  lymphocyte areas as compared 
with  wild-type  C57/B16  mice  (data  not  shown).  Previ- 
ously,  it  was shown  that MAdCAM-1  is  expressed  on si- 
nus-lining  cells  in  the  spleen  of wild-type  (15)  but not of 
TNFRp55 -/-  mice  (14).  However,  the functional role of 
MAdCAM-1  expression on splenic sinus-lining cells is un- 
clear, because antibodies to MAdCAM-1  or ot4137 integrin 
do  not  inhibit  lymphocyte  migration  to  the  spleen  (15). 
Together with previous findings showing a  normal devel- 
opment of  primary lymphoid organs in TNFRp55 -/- mice 
(10), the data presented here indicate a selective function of 
TNFR p55 for Peyer's patch organogenesis. 
We  next  examined  whether  lymphocyte  recruitment  to 
gut-associated lymphatic tissues may be impaired in TNFR 
p55  -/- mice. Flow cytometry analysis, however, clearly dem- 
onstrated  that TNFRp55 -/-  lymphocytes expressed adhe- 
sion  molecules  such  as  L-selectin,  or  integrins  Ix4137 and 
LFA-1 at normal levels as compared with wild-type C57B1/6 
mice (Fig. 3). Moreover, immunohistochemical analysis re- 
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TNFRp55 -/- and C57/B16 mice. 
For  histopathological  examina- 
tion,  tissues were  fixed in  10% 
buffered  formalin, embedded  in 
para~n,  and  tissue sections were 
stained  with  hematoxylin  and 
eosin.  Representative  spleen sec- 
tions of wild-type C57/B16 (a) or 
mice TNFRp55 -/- (b) are shown. 
For  immunoperoxidase  staining, 
sections of  snap-frozen spleen sam- 
ples derived from C57/B16 (c and 
e) or TNFRp55 -/- mice (d and f) 
were incubated with anti-CD45R/ 
B220 (c and d) or anti-CD3  (e and 
.D  mAbs. Original magnifications 
were at 2.5 (a and b) or 10 (c and  j0. 
vealed  that  in  TNFRp55 -/-  mice,  MAdCAM-1  was  ex- 
pressed  on  endothelial  cells  of the  small  intestine  and  on 
high  endothehal  cells in mesenteric lymph nodes  (data not 
shown).  MAdCAM-1  was also present  in high  density  on 
endothehal  cells of vessels of abnormal lymphoid aggregates 
located in the terminal ileum of some mutant mice (Fig.  1 d). 
Previous studies have shown that the integrin o~4~37, but 
not  cx4131, mediates lymphocyte adhesion  to Peyer's patch 
high  endothehal  venules  and  to  MAdCAM-1  (16,  17),  as 
well  as in  vivo  migration  of lymphocytes  to  mucosal  sites 
(13,  18).  Consistent with these findings,  gut-afferent mem- 
ory lymphocytes display an r  high,  [31  integrin  low phe- 
notype,  suggesting that they express high levels of integrin 
et4137 (19).  In addition,  LFA-1  and L-selectin contribute  to 
lymphocyte  migration  to  Peyer's  patches  (20,  21).  Taken 
together,  these  results  therefore  indicate  that  the  lack  of 
Peyer's patches in TNFRp55 -/-  mice does not result from 
a  defect in  lymphocyte  recruitment  to  mucosal  sites.  This 
conclusion  is  also  supported  by  our  finding  that  intraepi- 
thehal  lymphocytes  and  lamina  propria  IgA immunoblasts 
were present in the small intestine of mutant mice (Fig.  1, g 
and h). 
LT-cx  may  form  secreted  homotrimers  binding  to 
TNFRp55  and TNFRp75  or cell surface-bound heterotri- 
mers with  LT-[3  that  can interact with  the  LT-13 receptor 
(5,  22-25).  Therefore,  developmental  defects in lymphoid 
organogenesis  associated with  LT-c~ deficiency  may result 
from  the  lack  of signals  mediated  by  several  independent 
cytokine receptors. Recently,  it was reported that LT-c~  -/- 
mice  have  no  detectable  lymph  nodes  or  Peyer's  patches 
and that the organization of the splenic white pulp in T  and 
B  cell areas is disturbed  (6, 7).  The results presented  in this 
study  demonstrating  that  the  development  of  Peyer's 
patches is selectively controlled by the TNFRp55  therefore 
suggest  that  the  effects  of LT-a  on  the  development  of 
lymphoid  organs may be mediated by at least two  distinct 
receptors,  each  functioning  in  an  organ-specific  context. 
Thus, the data presented in this report partly refute the hy- 
pothesis that the effects of LT-o~ in lymphoid organ devel- 
opment  are  mediated  solely  by  the  LT-I3  receptor  (4). 
Since lymphatic organs develop normally in TNFRp75 -/- 
mice (12), it is tempting to speculate on a role of the LT-[3 
receptor for lymph node  development  and  formation  of a 
normal splenic architecture. 
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Figure 3.  Expression of adhesion molecules on lymphocytes  derived from TNFRp55 -/- or wild-type C57B1/6 mice. Lymphocytes  freshly isolated 
from lymph nodes of TNFRp55 -/- or C57B1/6 mice were incubated  with saturating amounts  of rat mAbs to L-selectin (MEL-14), a4-integrin (PS/2), 
137-integrin (Fib 30), or LFA-1 (FD441.8), washed, and stained with FITC-conjugated mouse anti-rat IgG F(ab')2 fragments. 
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